Around 39.6% of T1DM patients had anti-TPO, and 30% had anti-Tg antibodies in one study, but other studies reported variations of 7–40% for anti-TPO and around 15% for anti-Tg antibodies (102, 103). The gene discussed is TPO; the disease is type 1 diabetes mellitus.